Neuland Laboratories Dividendenrendite
Was ist das Dividendenrendite von Neuland Laboratories?
Dividendenrendite von Neuland Laboratories Limited ist 0.11%
Was ist die Definition von Dividendenrendite?
Die Dividendenrendite stellt das Verhältnis zwischen den an die Aktionäre ausgeschütteten Dividenden je Aktie und dem Marktpreis je Aktie über ein zurückliegendes Jahr dar.
The dividend yield or dividend-price ratio of a share is the dividend per share, divided by the price per share. It is also a company's total annual dividend payments divided by its market capitalization, assuming the number of shares is constant, and is often expressed as a percentage. The reciprocal of the dividend yield is the price-dividend ratio.
A higher dividend yield has been considered to be desirable among many investors. A high dividend yield can be considered to be evidence that a stock is underpriced or that the company has fallen on hard times and future dividends will not be as high as previous ones. Similarly a low dividend yield can be considered evidence that the stock is overpriced or that future dividends might be higher. Some investors may find a higher dividend yield attractive, for instance as an aid to marketing a fund to retail investors, or maybe because they cannot get their hands on the capital, which may be tied up in a trust arrangement. In contrast some investors may find a higher dividend yield unattractive, perhaps because it increases their tax bill.
Dividendenrendite von Unternehmen in Health Care Sektor auf BSE im Vergleich zu Neuland Laboratories
Was macht Neuland Laboratories?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Unternehmen mit dividendenrendite ähnlich Neuland Laboratories
- SMS Lifesciences India hat Dividendenrendite von 0.11%
- US Solar Fund Plc hat Dividendenrendite von 0.11%
- Keywords Studios plc hat Dividendenrendite von 0.11%
- Gokaldas Exports hat Dividendenrendite von 0.11%
- PNC Infratech hat Dividendenrendite von 0.11%
- Kotak Mahindra Bank hat Dividendenrendite von 0.11%
- Neuland Laboratories hat Dividendenrendite von 0.11%
- Linde India hat Dividendenrendite von 0.11%
- Texmaco Infrastructure & hat Dividendenrendite von 0.11%
- Coca-Cola Consolidated Inc hat Dividendenrendite von 0.11%
- SNC-Lavalin hat Dividendenrendite von 0.11%
- Avantel hat Dividendenrendite von 0.11%
- National Peroxide hat Dividendenrendite von 0.11%